Analysis

TC Heartland & Hatch-Waxman: The Sky's Not Falling

Law360, New York (June 9, 2017, 1:24 PM EDT) -- The U.S. Supreme Court's recent TC Heartland decision is poised to shake up patent litigation across the country, but the process for suing over abbreviated new drug applications and biosimilars under the Hatch-Waxman Act will likely remain undisrupted and keep cases in the usual venues, experts say.

The May 22 ruling — issued in a dispute between TC Heartland and Kraft Food Brands Group over water-flavoring drops — restricted civil patent infringement suits to wherever defendants are incorporated, or where they have committed infringing acts and also have established places of business. In doing so, the court's eight justices — minus Justice...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!